These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 34390300)

  • 21. Pharmacological Treatment of Cannabis-Related Disorders: A Narrative Review.
    Gorelick DA
    Curr Pharm Des; 2016; 22(42):6409-6419. PubMed ID: 27549375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial.
    McNamara RK; Strawn JR; Tallman MJ; Welge JA; Patino LR; Blom TJ; DelBello MP
    J Child Adolesc Psychopharmacol; 2020 Jun; 30(5):293-305. PubMed ID: 32167792
    [No Abstract]   [Full Text] [Related]  

  • 23. Cannabis use disorder is associated with greater illness severity in tobacco smoking patients with bipolar disorder.
    Lagerberg TV; Icick R; Andreassen OA; Ringen PA; Etain B; Aas M; Henry C; Bjella TD; Melle I; Bellivier F
    J Affect Disord; 2016 Jan; 190():286-293. PubMed ID: 26544611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group.
    Pande AC; Crockatt JG; Janney CA; Werth JL; Tsaroucha G
    Bipolar Disord; 2000 Sep; 2(3 Pt 2):249-55. PubMed ID: 11249802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of altered membrane phospholipid metabolism in the anterior cingulate cortex and striatum of patients with bipolar disorder I: A multi-voxel (1)H MRS study.
    Cao B; Stanley JA; Selvaraj S; Mwangi B; Passos IC; Zunta-Soares GB; Soares JC
    J Psychiatr Res; 2016 Oct; 81():48-55. PubMed ID: 27376506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial.
    D'Souza DC; Cortes-Briones J; Creatura G; Bluez G; Thurnauer H; Deaso E; Bielen K; Surti T; Radhakrishnan R; Gupta A; Gupta S; Cahill J; Sherif MA; Makriyannis A; Morgan PT; Ranganathan M; Skosnik PD
    Lancet Psychiatry; 2019 Jan; 6(1):35-45. PubMed ID: 30528676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis.
    Bojesen KB; Ebdrup BH; Jessen K; Sigvard A; Tangmose K; Edden RAE; Larsson HBW; Rostrup E; Broberg BV; Glenthøj BY
    Psychol Med; 2020 Oct; 50(13):2182-2193. PubMed ID: 31524118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Use of Cannabis as a Predictor of Early Onset of Bipolar Disorder and Suicide Attempts.
    Leite RT; Nogueira Sde O; do Nascimento JP; de Lima LS; da Nóbrega TB; Virgínio Mda S; Moreno LM; Sampaio BH; de Matos E Souza FG
    Neural Plast; 2015; 2015():434127. PubMed ID: 26097750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety.
    Laprevote V; Schwan R; Schwitzer T; Rolland B; Thome J
    Curr Pharm Des; 2015; 21(23):3298-305. PubMed ID: 26088109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in cannabis use disorder by cigarette smoking status in the United States, 2002-2016.
    Weinberger AH; Pacek LR; Wall MM; Zvolensky MJ; Copeland J; Galea S; Nahvi S; Moeller SJ; Hasin DS; Goodwin RD
    Drug Alcohol Depend; 2018 Oct; 191():45-51. PubMed ID: 30077055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of pregabalin maintenance on cannabis effects and related behaviors in daily cannabis users.
    Lile JA; Alcorn JL; Hays LR; Kelly TH; Stoops WW; Wesley MJ; Westgate PM
    Exp Clin Psychopharmacol; 2022 Oct; 30(5):560-574. PubMed ID: 33983765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower dACC glutamate in cannabis users during early phase abstinence.
    Zuo CS; Davis KA; Lukas SE
    Neuropsychopharmacology; 2022 Oct; 47(11):1969-1975. PubMed ID: 35484401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurofunctional changes in adolescent cannabis users with and without bipolar disorder.
    Bitter SM; Adler CM; Eliassen JC; Weber WA; Welge JA; Burciaga J; Shear PK; Strakowski SM; DelBello MP
    Addiction; 2014 Nov; 109(11):1901-9. PubMed ID: 24962329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial.
    Kirkland AE; Browning BD; Green R; Liu H; Maralit AM; Ferguson PL; Meyerhoff DJ; Prisciandaro JJ; Miranda R; Brady KT; Tomko RL; Gray KM; Squeglia LM
    Neuropsychopharmacology; 2023 Jul; 48(8):1184-1193. PubMed ID: 36878996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine.
    Tomko RL; Gilmore AK; Gray KM
    Addict Behav; 2018 Oct; 85():26-30. PubMed ID: 29803870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
    Levin FR; Mariani JJ; Pavlicova M; Brooks D; Glass A; Mahony A; Nunes EV; Bisaga A; Dakwar E; Carpenter KM; Sullivan MA; Choi JC
    Drug Alcohol Depend; 2016 Feb; 159():53-60. PubMed ID: 26711160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cigarette smoking and its relationship to mood disorder symptoms and co-occurring alcohol and cannabis use disorders following first hospitalization for bipolar disorder.
    Heffner JL; DelBello MP; Anthenelli RM; Fleck DE; Adler CM; Strakowski SM
    Bipolar Disord; 2012 Feb; 14(1):99-108. PubMed ID: 22329477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial.
    McRae-Clark AL; Gray KM; Baker NL; Sherman BJ; Squeglia L; Sahlem GL; Wagner A; Tomko R
    Drug Alcohol Depend; 2021 Dec; 229(Pt B):109111. PubMed ID: 34655945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.